23 Jul, 2026
According to Straits Research, the global membrane chromatography market, valued at $0.37 billion in 2025, is projected to grow from $0.43 billion in 2026 to $1.37 billion by 2034 at a CAGR of 15.69% during the forecast period 2026–2034.
Membrane chromatography is an advanced separation technique that utilizes porous membranes to isolate and purify biological macromolecules, including proteins. This technology is prevalent in bioprocessing applications and is particularly advantageous for the purification of proteins, viral particles, and monoclonal antibodies. By leveraging the selective permeability of membranes, this method facilitates efficient separation based on molecular size and interaction characteristics, enhancing yield and purity in downstream processing.
The global market is experiencing a surge in investments in research and development, which is driving innovation and advancements in purification technologies. Companies are increasingly focused on improving the efficiency, scalability, and versatility of membrane chromatography systems in biopharmaceutical processes. Moreover, leading industry players are expanding their facilities and investing in new infrastructure to bolster their research and manufacturing capabilities.
Membrane chromatography is increasingly being applied outside the pharmaceutical industry, creating new opportunities in sectors such as energy storage, food and beverage processing, water treatment, recycling, and chemical manufacturing. Its ability to improve separation efficiency, scalability, and sustainability makes it a valuable technology in these diverse fields.
North America maintains a leading position in the global market, fueled by significant investments in research and development (R&D) and healthcare and biomanufacturing sectors. The region’s widespread adoption of advanced purification technologies is further strengthened by the presence of major industry players like 3M, Microsolv, and Restek Corporation, which drive innovation and market growth. With a well-established healthcare infrastructure and rising demand for biologics, North America remains at the forefront of developing membrane chromatography solutions, solidifying its market dominance.
sales@straitsresearch.com